All News

Diane Powis spent more than 10 months bouncing from one doctor to the next before finally being “blindsided by” a diagnosis of stage 3 ovarian cancer. But as her initial feelings of isolation and fear wore off, Powis soon learned that she wasn’t alone – and that help and information were out there.

On social media, CURE® recently asked its readers to share what movies, books and TV shows helped them get through their cancer treatments.

Moment by moment, we move toward life. We feel what needs to be felt. We can even feel through the numb parts—the broken pieces. Instead of looking somewhere else, we look straight on— at ourselves and others. We see what’s really there. Who is there for us? Who is not? We choose to be with those we love, and those who love us back—like the person in the mirror, the new friend.

While aspirin has been shown to be a protective factor against colorectal cancer in younger adults, recent findings show that the benefit is nonexistent in individuals over the age of 70.

Results of a trial assessing endoxifen in patients with breast cancer in Australia were positive enough for the manufacturer to stop the trial before it was scheduled to be completed. The drug’s manufacturer will now accelerate its development in the U.S.

CURE® compiled a roundup of five recent pieces of diet and exercise-related news and updates that patients with cancer may have missed.

CURE® compiled a roundup of several recent stories that cancer caregivers may have missed.

At the moment it may be hard to realize, but your life is not over because of cancer.

The Food and Drug Administration on Friday approved Breyanzi, a cell-based gene therapy, for the treatment of adults with certain types of large B-cell lymphoma.

The Food and Drug Administration has granted an accelerated approval to Ukoniq for the treatment of certain adults with previously treated relapsed or refractory marginal zone lymphoma and relapsed or refractory follicular lymphoma.

While the threat of COVID-19 still looms across the country, the risks of delaying cancer screenings – or active surveillance for those patients who are currently in treatment – could be greater than people think, says City of Hope’s Dr. Ravi Salgia.

With a COVID-19 vaccine shot on the way, here are 5 groups of people I, as a cancer survivor, want to thank.

From a Pennsylvania-based nonprofit taking advantage of recent blizzards to help local families in need to the creation of a “Cancer Bill of Rights”, here’s what’s happening in the cancer landscape this week.

Survivors of testicular cancer sought out mental health services more often than the general population, according to recent research.

The Food and Drug Administration has given the greenlight for Bellicum Pharmaceuticals to continue enrolling patients on a trial assessing a novel therapy patients with previously treated metastatic pancreatic or prostate cancer.

Patients with rectal cancer who maintain a clinical complete response – meaning they are found to have no evidence of disease – after three years, may not need as frequent surveillance after that point, due to a decreased chance of regrowth and metastases.

A cancer survivor laments the difficulty of dealing with the pandemic and discusses one possible solution.

In this episode of the “CURE® Talks Cancer” podcast, we spoke with a patient who was blindsided by her stage 3 ovarian cancer diagnosis several years ago. We talk about how she spent months going from specialist to specialist before finally receiving her diagnosis, and why she dedicates much of her time to advocating for others.

To honor World Cancer Day 2021, CURE® has rounded up some of the most important 2021 cancer statistics to educate and inform.

Patients with prostate cancer experienced no significant difference in quality of life when treated with two different types of radiation regimens, recent research has found.

The Food and Drug Administration has granted an accelerated approval to Tepmetko for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose disease harbors mesenchymal-epithelial transition (MET) exon 14 skipping alterations.

A major diagnosis often forces us to shift the way we approach our lives, even once we’ve survived. So, what does it look like to chart a future having suffered in the past? And, how might we look forward?

An interim analysis of the PALLAS study showed that adding Ibrance to endocrine therapy, compared to endocrine therapy alone, after initial treatment ended for patients with HR-positive, HER2-negative, early-stage breast cancer did not extend the length of time before a patient’s disease recurred.

Treatment with sotorasib induced a 6.8-month median progression-free survival in patients with KRAS G12C–mutated advanced non-small cell lung cancer.

Onureg, an oral form of the chemotherapy azacitidine, in older patients with acute myeloid leukemia who were in remission after chemotherapy contributed to longer survival outcomes, compared to placebo.

Recent study results demonstrated that an at-home prehabilitation program may improve surgical outcomes in patients with lung cancer.

Looking at the small things we may miss or take for granted can help us appreciate the changes that come along with a cancer diagnosis and how to weather the bad times.

A survey conducted by the LUNGevity Foundation determined that 96% of patients with lung cancer felt that they were concerned about the COVID-19 pandemic affecting their treatment.

New study results demonstrate that patients with lung cancer have experienced more worries and general distress during the COVID-19 pandemic compared to other patients with cancer.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for January 2021.